PATENT CLAIM ANALYSIS

Application Number: 15961553
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["544", "280000"]

Abstract:
Disclosed are chemical entities of formula I: wherein X, Y, Z, R 1 , R 3 , R 4 , R 5  and R 6  are defined herein, as NR2B subtype selective receptor antagonists. Also disclosed are pharmaceutical compositions comprising a chemical entity of formula I, and methods of treating various diseases and disorders associated with NR2B antagonism, e.g., diseases and disorders of the CNS, such as depression, by administering a chemical entity of formula I.

Claim (Index 27):
The method of  claim 26 , wherein the disease or disorder is depression.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 91.0
- Lexical Diversity: 1.72549
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15428321', '15315812', '14855010', '15548594', '15578460']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7779812723344732
- 35 USC 102 Novelty (BERT): 0.5442722527664055
- Combined Prediction Score: 0.7546103703776665
- Mean Citation Score: 370.752534
- Max Citation Score: 397.77426
- Similarity Product: 251.9708761337757

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test